178 related articles for article (PubMed ID: 23982363)
1. Revealing the incidentalome when targeting the tumor genome.
Bombard Y; Robson M; Offit K
JAMA; 2013 Aug; 310(8):795-6. PubMed ID: 23982363
[No Abstract] [Full Text] [Related]
2. Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making.
Ross LF; Rothstein MA; Clayton EW
JAMA; 2013 Jul; 310(4):367-8. PubMed ID: 23917281
[No Abstract] [Full Text] [Related]
3. Tumor profiling and the incidentalome: patient decisions and risks.
Hofstatter E; Mehra K; Yushak M; Pusztai L
Future Oncol; 2015; 11(24):3299-305. PubMed ID: 26562094
[TBL] [Abstract][Full Text] [Related]
4. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
Knapp E
J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
[No Abstract] [Full Text] [Related]
5. Genomic test validation for incidental findings.
Park JY; Fortina P; Kricka LJ
Clin Chem; 2014 Feb; 60(2):292-3. PubMed ID: 23818443
[No Abstract] [Full Text] [Related]
6. Tumor-Only Sequencing Has Limitations.
Cancer Discov; 2015 Jul; 5(7):OF17. PubMed ID: 25929850
[No Abstract] [Full Text] [Related]
7. Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.
Green RC; Lupski JR; Biesecker LG
JAMA; 2013 Jul; 310(4):365-6. PubMed ID: 23917280
[No Abstract] [Full Text] [Related]
8. [The genome and cancer treatment].
Nielsen FC; Lassen U
Ugeskr Laeger; 2014 Nov; 176(46):. PubMed ID: 25394934
[TBL] [Abstract][Full Text] [Related]
9. Disclosure of Misattributed Paternity.
Prero MY; Strenk M; Garrett J; Kessler A; Fanaroff JM; Lantos JD
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31097466
[TBL] [Abstract][Full Text] [Related]
10. 'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.
Daack-Hirsch S; Driessnack M; Hanish A; Johnson VA; Shah LL; Simon CM; Williams JK
Clin Genet; 2013 Jul; 84(1):11-8. PubMed ID: 23590238
[TBL] [Abstract][Full Text] [Related]
11. Generating a taxonomy for genetic conditions relevant to reproductive planning.
Korngiebel DM; McMullen CK; Amendola LM; Berg JS; Davis JV; Gilmore MJ; Harding CO; Himes P; Jarvik GP; Kauffman TL; Kennedy KA; Simpson DK; Leo MC; Lynch FL; Quigley DI; Reiss JA; Richards CS; Rope AF; Schneider JL; Goddard KA; Wilfond BS
Am J Med Genet A; 2016 Mar; 170(3):565-73. PubMed ID: 26889673
[TBL] [Abstract][Full Text] [Related]
12. Genomic testing: a struggle for oncologists.
Hede K
J Natl Cancer Inst; 2014 Jun; 106(6):dju172. PubMed ID: 24907388
[No Abstract] [Full Text] [Related]
13. That tumor you're going to get tomorrow … maybe: making an informed decision.
Aitini E; Adami F; Barni S; Zaniboni A
Tumori; 2015 Jul; 101(4):e113-4. PubMed ID: 26045122
[TBL] [Abstract][Full Text] [Related]
14. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
Ackerman SL; Koenig BA
AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
[TBL] [Abstract][Full Text] [Related]
15. Genome sequencing and cancer.
Mardis ER
Curr Opin Genet Dev; 2012 Jun; 22(3):245-50. PubMed ID: 22534183
[TBL] [Abstract][Full Text] [Related]
16. Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment.
Konnick EQ; Pritchard CC
Genome Med; 2016 Oct; 8(1):100. PubMed ID: 27716394
[TBL] [Abstract][Full Text] [Related]
17. From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine.
Ku CS; Roukos DH
Expert Rev Med Devices; 2013 Jan; 10(1):1-6. PubMed ID: 23278216
[No Abstract] [Full Text] [Related]
18. Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families.
Lynch HT; Brand RE; Lynch JF; Fusaro RM; Smyrk TC; Goggins M; Kern SE
Gastroenterology; 2000 Dec; 119(6):1756-60. PubMed ID: 11113097
[TBL] [Abstract][Full Text] [Related]
19. Medicine. Personalized cancer diagnostics.
Corless CL
Science; 2011 Dec; 334(6060):1217-8. PubMed ID: 22144608
[No Abstract] [Full Text] [Related]
20. Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management.
Giri VN; Hyatt C; Gomella LG
J Clin Oncol; 2019 Jun; 37(17):1455-1459. PubMed ID: 30978156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
